Braun Stacey Associates Inc Horizon Therapeutics Public LTD CO Transaction History

Braun Stacey Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$79.4 - $116.36 $1.62 Million - $2.38 Million	-20,423 Reduced 8.53%	218,869 $17.5 Million
Q1 2022 Apr 28, 2022	SELL	$86.42 - $109.81 $989,509 - $1.26 Million	-11,450 Reduced 4.57%	239,292 $25.2 Million
Q4 2021 Jan 25, 2022	BUY	$98.56 - $119.91 $20,697 - $25,181	210 Added 0.08%	250,742 $27 Million
Q3 2021 Dec 01, 2021	SELL	$91.91 - $110.37 $1.03 Million - $1.24 Million	-11,200 Reduced 4.28%	250,532 $27.4 Million
Q2 2021 Jul 23, 2021	BUY	$86.24 - $95.92 $23,543 - $26,186	273 Added 0.1%	261,732 $24.5 Million
Q1 2021 Apr 28, 2021	BUY	$71.83 - $95.48 $710,183 - $944,010	9,887 Added 3.93%	261,459 $24.1 Million
Q4 2020 Feb 03, 2021	BUY	$67.0 - $84.39 $16.9 Million - $21.2 Million	251,572 New	251,572 $18.4 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Braun Stacey Associates Inc with notifications on news.